FDA Says Medicis’ 510(k) Application to Market LIPOSONIX Does Not Provide Sufficient Data

July 6 (Reuters) - Medicis Pharmaceutical Corp (MRX.N) said health regulators indicated in a letter last week that data in its current filing for marketing approval of its body sculpting device, LipoSonix, was not sufficient.